208 related articles for article (PubMed ID: 34068749)
1. Synergistic Effect of Perampanel and Temozolomide in Human Glioma Cell Lines.
Salmaggi A; Corno C; Maschio M; Donzelli S; D'Urso A; Perego P; Ciusani E
J Pers Med; 2021 May; 11(5):. PubMed ID: 34068749
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor effects of perampanel in malignant glioma cells.
Tatsuoka J; Sano E; Hanashima Y; Yagi C; Yamamuro S; Sumi K; Hara H; Takada K; Kanemaru K; Komine-Aizawa S; Katayama Y; Yoshino A
Oncol Lett; 2022 Dec; 24(6):421. PubMed ID: 36284648
[TBL] [Abstract][Full Text] [Related]
3. Anti‑tumor effects of anti‑epileptic drugs in malignant glioma cells.
Yagi C; Tatsuoka J; Sano E; Hanashima Y; Ozawa Y; Yoshimura S; Yamamuro S; Sumi K; Hara H; Katayama Y; Yoshino A
Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36281939
[TBL] [Abstract][Full Text] [Related]
4. AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro.
Lange F; Weßlau K; Porath K; Hörnschemeyer MF; Bergner C; Krause BJ; Mullins CS; Linnebacher M; Köhling R; Kirschstein T
PLoS One; 2019; 14(2):e0211644. PubMed ID: 30716120
[TBL] [Abstract][Full Text] [Related]
5. Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma.
Ni XR; Guo CC; Yu YJ; Yu ZH; Cai HP; Wu WC; Ma JX; Chen FR; Wang J; Chen ZP
Cancer Chemother Pharmacol; 2020 Dec; 86(6):773-782. PubMed ID: 33074386
[TBL] [Abstract][Full Text] [Related]
6. Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
Aghi M; Rabkin S; Martuza RL
J Natl Cancer Inst; 2006 Jan; 98(1):38-50. PubMed ID: 16391370
[TBL] [Abstract][Full Text] [Related]
7. Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models.
Zwart R; Sher E; Ping X; Jin X; Sims JR; Chappell AS; Gleason SD; Hahn PJ; Gardinier K; Gernert DL; Hobbs J; Smith JL; Valli SN; Witkin JM
J Pharmacol Exp Ther; 2014 Oct; 351(1):124-33. PubMed ID: 25027316
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Anticancer Effects of Formononetin and Temozolomide on Glioma C6 Cells.
Zhang X; Ni Q; Wang Y; Fan H; Li Y
Biol Pharm Bull; 2018 Aug; 41(8):1194-1202. PubMed ID: 29848900
[TBL] [Abstract][Full Text] [Related]
9. Synergism of perampanel and zonisamide in the rat amygdala kindling model of temporal lobe epilepsy.
Russmann V; Salvamoser JD; Rettenbeck ML; Komori T; Potschka H
Epilepsia; 2016 Apr; 57(4):638-47. PubMed ID: 26854031
[TBL] [Abstract][Full Text] [Related]
10. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive perampanel for glioma-associated epilepsy.
Dunn-Pirio AM; Woodring S; Lipp E; Herndon JE; Healy P; Weant M; Randazzo D; Desjardins A; Friedman HS; Peters KB
Epilepsy Behav Case Rep; 2018; 10():114-117. PubMed ID: 30377587
[TBL] [Abstract][Full Text] [Related]
12. [Glioblastoma].
Tanaka S
No Shinkei Geka; 2021 May; 49(3):623-631. PubMed ID: 34092568
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatography-tandem mass spectrometry method for the determination of perampanel, a novel α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist in human plasma.
Mano Y; Takenaka O; Kusano K
J Pharm Biomed Anal; 2015 Mar; 107():56-62. PubMed ID: 25569285
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic and Senolytic Effects of Methadone in Combination with Temozolomide in Glioblastoma Cells.
Kaina B; Beltzig L; Piee-Staffa A; Haas B
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977591
[TBL] [Abstract][Full Text] [Related]
16. Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In Vivo.
Vaglini F; Pardini C; Di Desidero T; Orlandi P; Pasqualetti F; Ottani A; Pacini S; Giuliani D; Guarini S; Bocci G
Mol Neurobiol; 2018 Jun; 55(6):4984-4997. PubMed ID: 28791594
[TBL] [Abstract][Full Text] [Related]
17. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway.
Fu J; Zhu SH; Xu HB; Xu YQ; Wang X; Wang J; Kong PS
J Ethnopharmacol; 2020 Oct; 261():113071. PubMed ID: 32603676
[TBL] [Abstract][Full Text] [Related]
18. Perampanel: What is its Place in the Management of Partial Onset Epilepsy?
Ledingham DR; Patsalos PN
Neurol Ther; 2013 Dec; 2(1-2):13-24. PubMed ID: 26000213
[TBL] [Abstract][Full Text] [Related]
19. Pilot trial of perampanel on peritumoral hyperexcitability and clinical outcomes in newly diagnosed high-grade glioma.
Tobochnik S; Regan MS; Dorotan MKC; Reich D; Lapinskas E; Hossain MA; Stopka S; Santagata S; Murphy MM; Arnaout O; Bi WL; Antonio Chiocca E; Golby AJ; Mooney MA; Smith TR; Ligon KL; Wen PY; Agar NYR; Lee JW
medRxiv; 2024 Apr; ():. PubMed ID: 38645003
[TBL] [Abstract][Full Text] [Related]
20. A Liquid Chromatography-Mass Spectrometry Assay for Determination of Perampanel and Concomitant Antiepileptic Drugs in the Plasma of Patients With Epilepsy Compared With a Fluorescent HPLC Assay.
de Grazia U; DʼUrso A; Ranzato F; De Riva V; Contarato G; Billo G; Perini F; Galloni E
Ther Drug Monit; 2018 Aug; 40(4):477-485. PubMed ID: 29746395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
